COMMERCIALIZING WORLD-CLASS CANCER INNOVATION

Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.

ONTARIO RESEARCH Leveraging breakthrough innovation and community network COMMERCIALIZATION VENTURE Investing seed capital, creating & scaling start-ups, securing strategic partners PATIENT & ECONOMIC IMPACT Driving clinical trials, job creation ,talent development, sustainable biotech in Ontario ONTARIO RESEARCH Leveraging breakthrough innovation and community network COMMERCIALIZATION VENTURE Investing seed capital, creating & scaling start-ups, securing strategic partners PATIENT & ECONOMIC IMPACT Driving clinical trials, job creation ,talent development, sustainable biotech in Ontario

OUR IMPACT

Increasing the value of Ontario’s best oncology innovations and attracting investment from the private sector (current as of November 2021).

In total funding and equity investments

In additional financing attracted

Ontario start-ups created

First-in-human studies

PORTFOLIO

Our investments are at the forefront of Ontario’s biotech ecosystem.

FIND OUT MORE

FUNDS

Our investments bridge the life sciences seed funding gap.

FIND OUT MORE

KEY SUCCESSES

Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.

RECENT NEWS

Keep up to date on our investments and business developments in recent news stories and summaries.

  • FACIT broadens Executive-in-Residence program to capitalize on Ontario IP

    November 30, 2021 – The appointment broadens the available expertise to provide critical senior management and leadership to create and nurture FACIT start-ups in Ontario. Read More from FACIT broadens Executive-in-Residence program to capitalize on Ontario IP

  • FACIT Features: Radiant Biotherapeutics, next-gen biotech developing multabody therapies for cancer

    October 21, 2021 – Radiant received a seed investment from FACIT’s Compass Rose Oncology Fund. Read More from FACIT Features: Radiant Biotherapeutics, next-gen biotech developing multabody therapies for cancer

  • FACIT Features: Replica Analytics, Ottawa-based start-up in health data artificial intelligence

    October 13, 2021 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it. Read More from FACIT Features: Replica Analytics, Ottawa-based start-up in health data artificial intelligence

We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives. 

FACIT is funded in part by the Government of Ontario through OICR